Showing results (2151-2160 of 2,188) with videos related to
Sort By:
Pageof 219
Biorxiv : the Preprint Server for Biology|June 9, 2020
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaquesNeeltje van Doremalen, Teresa Lambe, Alexandra Spencer, et al.Journal of Medicinal Chemistry|February 11, 2025
Identification of Structurally Novel KRASG12C Inhibitors through Covalent DNA-Encoded Library ScreeningDavid Huang, Francesco Manoni, Zhen Sun, et al.Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order AmishE I Ginns, P St Jean, R A Philibert, et al.Nature|July 31, 2020
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaquesNeeltje van Doremalen, Teresa Lambe, Alexandra Spencer, et al.Journal of Medicinal Chemistry|March 18, 2025
From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo EfficacyIan Sarvary, Mikkel Vestergaard, Loris Moretti, et al.Nature|February 26, 2016
The host galaxy of a fast radio burstE F Keane, S Johnston, S Bhandari, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 2, 2023
Personalized diagnosis in suspected myocardial infarctionJohannes Tobias Neumann, Raphael Twerenbold, Francisco Ojeda, et al.Journal of the American College of Cardiology|February 26, 2021
Comparison of Management Strategies for Neonates With Symptomatic Tetralogy of FallotBryan H Goldstein, Christopher J Petit, Athar M Qureshi, et al.Cancer Discovery|September 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted CancersBrian Belmontes, Katherine K Slemmons, Chun Su, et al.Journal of Medicinal Chemistry|July 14, 2026
Expanding Addressable KRAS Mutations through the Structure- and Property-Based Design of Dual-State (GDP/GTP), Reversible Pan-KRAS InhibitorsRyan P Wurz, Jennifer R Allen, John G Allen, et al.Pageof 219